Taiwan’s “Healthy Taiwan” vision is driving a fast shift toward digital health. The core idea is to integrate big data, artificial intelligence (AI), and cloud technologies so care becomes more holistic and person-centered. Taiwan’s foundation includes a strong ICT industry and its National Health Insurance (NHI) system, which has accumulated high-quality healthcare data over time. That data base is now being positioned as a practical asset for digital transformation. The goal is not just new tools, but a new operating model that improves healthcare quality and efficiency while extending services from hospitals into communities and daily life.
A key building block is a national digital health platform described as the “3-3-3 Framework.” It integrates three major health spaces, three key health data standards, and three national AI governance centers to form a broad digital health infrastructure. Under this approach, Taiwan is promoting integration of electronic medical records across more than 400 hospitals nationwide. International standards are part of the plan, including Fast Healthcare Interoperability Resources (FHIR), to support cross-institutional interoperability. The framework is paired with a Zero Trust cybersecurity approach so data can be shared securely while still being usable for clinical and system improvement.
From National Platforms to Everyday Clinical Use
Several national platforms show how cloud-connected records and big data can translate into daily clinical workflows. The MediCloud system provides real-time access to patient records and medication information, supporting safer decisions at the point of care. Enhanced visualization of examination results and AI-assisted medical imaging interpretation are also described as improving healthcare quality and patient safety. For chronic disease management, the “Family Physician Platform” incorporates AI-based risk prediction to help physicians deliver more personalized care. This supports a shift from reactive treatment toward proactive health management, which aligns with Taiwan’s emphasis on person-centered, holistic care.
Personal health management is also being expanded through digital access and integration. Taiwan’s “My Health Bank” platform has surpassed a 50% adoption rate, and it can integrate data from wearable devices. This is framed as a way to encourage individuals to take a more active role in managing their own health, not only during hospital visits. In cancer care digitalization, Taiwan uses the FHIR standard to exchange Next-Generation Sequencing (NGS) data. This helps accelerate the review process for catastrophic illness certification and related medical use, supporting access to timely treatment as administrative and clinical data exchange becomes more automated.
Governance and validation are positioned as essential to scaling clinical AI responsibly. Taiwan has established nineteen national medical AI centers that cover responsible governance, clinical validation, and impact evaluation, aiming to ensure AI is safe and reliable across its lifecycle. In terms of adoption signals, more than 50 AI medical products have received regulatory approval, supporting early cancer detection, prediction of cardiac events, and clinical decision-making support. Taiwan also has 13 hospitals ranked among Newsweek’s “World’s Best Smart Hospitals 2026,” placing second in Asia. Together, these developments illustrate how AI-driven healthcare in Taiwan is being tied to standards, platforms, and oversight rather than isolated pilots.
What is driving AI-driven healthcare modernization in Taiwan?
How does Taiwan enable interoperability across hospitals?
What adoption milestone has My Health Bank reached?
How is Taiwan governing clinical AI development?
What does the AI Driven Healthcare Taiwan approach show in terms of results?
